CBD Life Sciences Inc. (CBDL) Announces CBG Emerges as a

New Post Public Reply Private Reply Replies (1) Message Board
louied91
175
CBD Life Sciences Inc. (CBDL) Announces CBG Emerges as a Promising Focus in
Cancer Research Initiatives


https://www.otcmarkets.com/news-otcapi/news/d...d?id=89467

With the global cannabinoid market projected to surpass $50+ billion in the coming years and segments like minor cannabinoids expected to grow at double-digit CAGR, cannabigerol (CBG) is rapidly emerging as a high-growth frontier—drawing attention for its non-psychoactive profile and early-stage research highlighting potential roles in oncology pathways and treatment support.

SCOTTSDALE, AZ / March 24, 2026 / — CBD Life Sciences Inc. (OTC: CBDL), an emerging leader in cannabinoid innovation and high-growth wellness markets, today announced a major expansion of its CBG-focused product program, strategically positioning the Company at the forefront of one of the most promising segments in the evolving cannabinoid landscape.

The expansion includes the launch of CBG-infused vape cartridges, tinctures, and advanced pain relief creams, as CBDL aligns with accelerating scientific interest and consumer demand surrounding cannabigerol (CBG).

CBG: A Next-Generation Cannabinoid Gaining Scientific Traction

While the U.S. Food and Drug Administration (FDA) has not approved CBG as a treatment for cancer, a growing body of preclinical research is driving increased attention from both the scientific community and investors.

Studies published through respected research institutions, including the National Institutes of Health (NIH) and PubMed Central (PMC), suggest that CBG may influence cancer-related biological pathways through several mechanisms:

[list]
[*]Inducing apoptosis (programmed cell death) in cancer cells, including colorectal carcinoma, glioblastoma, and leukemia
[*]Disrupting tumor growth cycles through cell cycle arrest
[*]Interacting with key receptors such as TRPM8 and PPARγ, which are associated with tumor progression and suppression
[*]Targeting therapy-resistant cancer stem cells, particularly in aggressive cancers like glioblastoma
[/list]

These early findings are fueling increased global interest in CBG as a compound of significance in next-generation cannabinoid research.

Expanding Role in Supportive Care Markets

In addition to tumor-related research, CBG is being explored for its potential to support patients undergoing conventional treatments such as chemotherapy—an area representing a significant and growing market opportunity:

[list]
[*]Appetite stimulation without psychoactive effects
[*]Neuropathic pain relief, including chemotherapy-induced nerve damage
[*]Nausea modulation, with ongoing research into dosage optimization
[/list]

This dual potential—spanning both research-driven oncology interest and high-demand wellness applications—positions CBG as a uniquely valuable cannabinoid within the industry.

CBDL Expands Product Portfolio to Capture Demand

CBD Life Sciences is actively capitalizing on this momentum with a targeted rollout of premium CBG products designed for scalability, consumer adoption, and market differentiation:

[list]
[*]CBG Vape Cartridges – Fast-acting delivery for immediate absorption
[*]CBG Tinctures – Precise, versatile dosing for daily wellness routines
[*]CBG Pain Relief Creams – Advanced topical formulations targeting inflammation and localized discomfort
[/list]

This expansion reflects CBDL's commitment to innovation, product diversification, and capturing emerging high-margin categories within the cannabinoid sector.

Leadership Perspective: Positioning for Long-Term Growth

"CBG represents one of the most exciting opportunities we've seen in the cannabinoid space," said Lisa Nelson, President and Chief Executive Officer of CBD Life Sciences Inc. "As research continues to uncover its potential, we are moving aggressively to position CBDL at the center of this emerging market. Our focus is on building a strong product ecosystem around CBG while delivering long-term value to our shareholders."

Strategic Alignment with a High-Growth Industry

As the cannabinoid market continues its rapid expansion, CBG is quickly emerging as a key differentiator for forward-thinking companies. Its non-psychoactive nature, combined with increasing scientific attention and consumer awareness, is driving a new wave of demand across both retail and research-driven segments.

CBDL believes its early entry and focused investment in CBG product development positions the Company to:

[list]
[*]Capture first-mover advantage in an emerging cannabinoid category
[*]Expand market share across multiple product verticals
[*]Strengthen brand authority in next-generation cannabinoid innovation
[*]Drive long-term revenue growth and shareholder value
[/list]
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Four Pending Deals Put Shareholder Terms Under Scrutiny

Updated Category News Views 55

Four corporate transactions landed under a legal microscope on November 18, and that is never background noise for shareholders trying to judge whether the paperwork matches the price. Halper Sadeh LLC says it is investigating proposed deals involving WaFd, Personalis, Dana and Baldwin Group for possible federal securities-law violations and/or fiduciary-duty breaches....

Continue Reading
Novo and nference Push Whole-Body Data Into Research

Updated Category News Views 0

Cardiometabolic medicine has spent too long staring at single numbers while the rest of the body keeps waving its arms. Novo Nordisk’s newly announced collaboration with nference is an attempt to widen that lens, combining Novo’s clinical-trial research with nference’s AI technology and federated healthcare data network. The target is not small: obesity, diabetes,...

Continue Reading
PSEG Declares $0.67 Fourth-Quarter 2026 Cash Dividend

Updated Category News Views 159

A 67-cent utility dividend rarely sets the tape on fire, and that is precisely the point. Public Service Enterprise Group declared a regular fourth-quarter 2026 common-stock dividend of $0.67 per share, payable on or before December 31 to shareholders of record on December 10. For owners of NYSE:PEG, this is the sort of announcement that belongs in the “steady as she...

Continue Reading
Caracal’s $200K VMI Pledge Targets Cadet Affordability

Updated Category News Views 197

A tuition award can still leave a brutal hole in the budget. That is the plain fact sitting underneath Caracal Products & Services’ $200,000 commitment to Virginia Military Institute. Federal ROTC scholarships can cover tuition, but VMI says room, board and quartermaster fees average about $15,000 annually. For a student who has done everything right—earned the ROTC...

Continue Reading
Yeahka Bids to Lead AI Shopping Evolution

Updated Category News Views 115

AI Shopping: A New Frontier or A Sisyphean Task? The evolution of AI from sassy recommendation tools to transaction-executing agents is shaking up the retail sector. Enter Stage Left: Yeahka Limited (9923.HK), a payment tech outfit that's wading into this murky digital swamp. With YeahPay and Fushi Tech, they're trying to hammer out a blueprint for AI-friendly commerce...

Continue Reading
New Flight Charters Puts a Cap on Winter Surprises

Updated Category News Views 175

Ice on a wing is routine; ice on an invoice is where charter customers start muttering. New Flight Charters says it will again absorb de-icing and hangar charges this winter, up to $2,500 per trip, marking the seventh consecutive season for the program. In a business where the headline quote can look tidy and the final bill can arrive wearing muddy boots, that is a...

Continue Reading
ETCO Targets the Unflashy Weak Link in Battery Storage

Updated Category News Views 0

A battery cabinet can look impressive right up until one lousy connection becomes the problem nobody budgeted for. ETCO Incorporated’s new lineup of standard and custom connectors and terminals goes after that unglamorous part of battery energy storage systems: the physical handoff points carrying power, grounding equipment, and tying auxiliary components together. It...

Continue Reading
ZAKSIMLAB Tests Kombucha and Salmon Snack Pairing in Cafes

Updated Category News Views 148

A fish-based chip beside a fizzy tea mix is an odd little commercial wager, and that is exactly why ZAKSIMLAB's latest move deserves a look. The Seoul food brand launched Salmon Crunch Protein Chips in September, then put the snack next to its powdered kombucha at the 2026 Cafe & Bakery Fair Season 2. This is not a grand earnings story; no sales, pricing, store-count, or...

Continue Reading
Mining's Biodiversity Map Sharpens Location Risks

Updated Category News Views 11

Twelve thousand pins on a map do not settle the mining industry's nature problem, but they do make it much harder to pretend the problem is evenly spread. ICMM's new Global Mining and Metals Biodiversity Dataset overlays 12,000 large-scale formal mining, smelting, refining and processing facilities with ecosystem-condition and conservation indicators. For investors...

Continue Reading
SteriLance Aims for Smoother Pricks with NanoSense Move

Updated Category News Views 72

Revamping the Lancing Game Out there in Suzhou, SteriLance Medical is steering clear of just chasing meter accuracy—do enough folks even care about glorified electronics?—they're zeroing in on the needle part of the blood glucose test, the part that pricks your finger every damn day. Yep, this new initiative is inviting blood glucose monitoring (BGM) brands to embrace...

Continue Reading

Top 5 Most Recently Viewed Articles

Aterian Prepares for Upcoming Earnings Call This Quarter

Updated Category News Views 141

Aterian's Upcoming Financial Results Announcement Aterian, Inc. (Nasdaq: ATER), a prominent player in the consumer products sector, is gearing up to reveal its financial performance for the second quarter. Scheduled for Wednesday in the coming week, this announcement will take place after market closure, providing investors with valuable insights into the company’s...

Continue Reading
Updated Disclosure Insights for Balanced Commercial Property Trust

Updated Category News Views 70

Understanding the Recent Disclosure from Rathbones Group Plc Regarding Balanced Commercial Property Trust Limited This article offers a crucial overview of the recent disclosure made by Rathbones Group Plc about its interests in Balanced Commercial Property Trust Limited. Grasping these disclosures is essential for investors who want to effectively maneuver through the...

Continue Reading
TerraVolta Resources Secures Major Funding for Lithium Project

Updated Category News Views 219

TerraVolta Resources Lands Major Funding for Lithium Initiative Exciting developments are unfolding in the critical minerals sector as TerraVolta Resources, LLC, a key player in this field, has been chosen to negotiate a substantial $225 million funding award from the U.S. Department of Energy (DOE). This funding is set to support the establishment of a groundbreaking...

Continue Reading
Shining Moments of Natural Diamonds at the Golden Globes

Updated Category News Views 142

Shining Moments of Natural Diamonds at the Golden Globes This year's Golden Globes red carpet was captivating, showcasing natural diamonds that enchanted audiences and attendees alike. Rather than adhering to the conventional white diamond look, celebrities embraced a vibrant palette of colored diamonds. This trend was not just about sparkle but deeply reflected...

Continue Reading
iQIYI Plans Major Offering of Convertible Senior Notes

Updated Category News Views 122

iQIYI Plans a Significant Offering of Convertible Senior Notes iQIYI, Inc. (Nasdaq: IQ) is making headlines with its recent announcement regarding a substantial offering. The company plans to issue $300 million in convertible senior notes, reflecting its ongoing commitment to strengthen its financial position and enhance shareholder value. Details of the Convertible...

Continue Reading